C S Freitas - JoVE Visualize

Showing results (11-20 of 28) with videos related to

Pageof 3

Sort By:

Developmental Immunology|December 16, 1998

Epidermal growth factor modulates fetal thymocyte growth and differentiationC S Freitas, S R Dalmau, K Kovary, et al.

Developmental Immunology|January 1, 1995

In vivo and in vitro expression of tenascin by human thymic microenvironmental cellsC S Freitas, J S Lyra, S R Dalmau, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 1, 1986

Murine inflammatory factor co-chromatographs with murine interleukin-2 activityC S Freitas, T O Shinzato, C M Maciel, et al.

One Health (Amsterdam, Netherlands)|November 29, 2023

Blood meals from 'dead-end' vertebrate hosts enhance transmission potential of malaria-infected mosquitoesAshutosh K Pathak, Justine C Shiau, Rafael C S Freitas, et al.

JAMA|January 15, 2020

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.

Human Brain Mapping|April 22, 2010

Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform methodJ L Lancaster, L H Rainey, J L Summerlin, et al.

Biomaterials|October 31, 2003

Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with beta-cyclodextrinZ R Domingues, M E Cortés, T A Gomes, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|December 17, 2016

Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studiesE L Andrade, A F Bento, J Cavalli, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|October 27, 2016

Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studiesE L Andrade, A F Bento, J Cavalli, et al.

Journal of Biotechnology|November 7, 2017

A study of bio-hybrid silsesquioxane/yeast: Biosorption and neuronal toxicity of leadBianca Trama-Freitas, Johnattan C S Freitas, Rui C Martins, et al.

Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:

Pageof 3

Developmental Immunology|December 16, 1998

Epidermal growth factor modulates fetal thymocyte growth and differentiationC S Freitas, S R Dalmau, K Kovary, et al.

Developmental Immunology|January 1, 1995

In vivo and in vitro expression of tenascin by human thymic microenvironmental cellsC S Freitas, J S Lyra, S R Dalmau, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 1, 1986

Murine inflammatory factor co-chromatographs with murine interleukin-2 activityC S Freitas, T O Shinzato, C M Maciel, et al.

One Health (Amsterdam, Netherlands)|November 29, 2023

Blood meals from 'dead-end' vertebrate hosts enhance transmission potential of malaria-infected mosquitoesAshutosh K Pathak, Justine C Shiau, Rafael C S Freitas, et al.

JAMA|January 15, 2020

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.

Human Brain Mapping|April 22, 2010

Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform methodJ L Lancaster, L H Rainey, J L Summerlin, et al.

Biomaterials|October 31, 2003

Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with beta-cyclodextrinZ R Domingues, M E Cortés, T A Gomes, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|December 17, 2016

Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studiesE L Andrade, A F Bento, J Cavalli, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|October 27, 2016

Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studiesE L Andrade, A F Bento, J Cavalli, et al.

Journal of Biotechnology|November 7, 2017

A study of bio-hybrid silsesquioxane/yeast: Biosorption and neuronal toxicity of leadBianca Trama-Freitas, Johnattan C S Freitas, Rui C Martins, et al.

Pageof 3